Meinten Sie :
5 Firmen mit Ergebnissen für "hemagglutinin"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

27 Ergebnisse für "hemagglutinin" unter Somagenetix

Alternative Recognition of the Conserved Stem Epitope in Influenza ...

... Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3 ... , with its heavy chain encoded by VH3-30, was isolated using phage display with immobilized hemagglutinin ... Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3 ... Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3 ... Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3 ...

Heterosubtypic antibodies to influenza A virus have limited activit...

... hemagglutinin (HA)-mediated fusion of the viral membrane with the endosomal membrane. The epitopes recognized by ... antibodies (hMAbs) can neutralize multiple strains and subtypes by preventing hemagglutinin (HA)-mediated ... monoclonal antibodies (hMAbs) can neutralize multiple strains and subtypes by preventing hemagglutinin (HA ... antibodies (hMAbs) can neutralize multiple strains and subtypes by preventing hemagglutinin (HA)-mediated ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

6 Ergebnisse für "hemagglutinin" unter University of Zurich

Rac regulates giardia lamblia encystation by coordinating cyst wall...

... early maturation of ESVs. Quantitative analysis of cells expressing constitutively active hemagglutinin ... ESVs. Quantitative analysis of cells expressing constitutively active hemagglutinin (HA)-tagged GlRac ... early maturation of ESVs. Quantitative analysis of cells expressing constitutively active hemagglutinin ... ESVs. Quantitative analysis of cells expressing constitutively active hemagglutinin (HA)-tagged GlRac ...

Browse by Communities & Collections - Zurich Open Repository and Archive

Browse by Communities & Collections - Zurich Open Repository and Archive, http://www.zora.uzh.ch/view/subjectsnew/10028.html, Browse by Communities & Collections - Zurich Open Repository and Archi...

Mehr Ergebnisse

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Wagistrasse 25

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Wagistrasse 25

8952 Schlieren

1 Ergebnisse für "hemagglutinin" unter CSL Vifor

News Releases | CSL

... A(H1N1) to co-express two influenza antigens, hemagglutinin (HA) and neuraminidase (NA), raising ... two influenza antigens, hemagglutinin (HA) and neuraminidase (NA), raising potent immune responses in ...

ETH Zürich - Numerische Materialmodellierung

http://mohr.ethz.ch/  

8005 Zürich, Technoparkstrasse 1 / Einstein PFA G 11 (2. OG)

ETH Zürich - Numerische Materialmodellierung

Technoparkstrasse 1

8005 Zürich

2 Ergebnisse für "hemagglutinin" unter ETH Zürich - Numerische Materialmodellierung

Iron Deficiency Anemia at Time of Vaccination Predicts Decreased Va...

... mo (p = 0.0182, p = 0.0360); (B) anti-pertussis filamentous hemagglutinin-IgG at 24 wk (p = 0.0423 ... tetanus toxoid, pertussis (pertussis toxin, filamentous hemagglutinin (FHA), and pertactin) measles and ... mo (p = 0.0182, p = 0.0360); (B) anti-pertussis filamentous hemagglutinin-IgG at 24 wk (p = 0.0423 ... tetanus toxoid, pertussis (pertussis toxin, filamentous hemagglutinin (FHA), and pertactin) measles and ...

Mechanical stress impairs pheromone signaling via Pkc1-mediated reg...

... hemagglutinin epitope embedded in the protA-H3 tag (α-HA). The asterisk marks an unspecific band. van Drogen et ... hemagglutinin epitope embedded in the protA-H3 tag (α-HA). The asterisk marks an unspecific band. van Drogen et ...

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

1 Ergebnisse für "hemagglutinin" unter Roche Glycart AG

SARS-CoV-2 & Flu A/B Rapid Antigen Test​

... ) * Hemagglutinin (H or HA), Neuraminidase (N or NA)  How to perform a test   Testing process for the SARS-CoV-2 ...

Nach oben